Evidence map›Paper›PMID 41298450›Full record

ArticleNature communications2025

Calcitonin receptor downregulation and exercise-conditioned blood enable systemic muscle stem cell proliferation.

Lidan Zhang, Takayuki Kaji, Ayasa Nakamura, Nagomu Maesawa, Kanako Iwamori, Jiayao Xu, Yilin Liu, Akiyoshi Uezumi, Daisuke Kamimura, Masaaki Murakami and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lidan ZhangCenter for Medical Epigenetics, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China. zhangsi89818@gmail.com.ORCID http://orcid.org/0009-0008-0982-4934
Takayuki KajiLaboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.
Ayasa NakamuraLaboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.
Nagomu MaesawaLaboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.ORCID http://orcid.org/0009-0002-7244-4893
Kanako IwamoriLaboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.
Jiayao XuLaboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.ORCID http://orcid.org/0009-0000-4145-8227
Yilin LiuLaboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.
Akiyoshi UezumiDivision of Cell Heterogeneity, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Daisuke KamimuraDivision of Molecular Psychoimmunology, Institute for Genetic Medicine, and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Masaaki MurakamiDivision of Molecular Psychoimmunology, Institute for Genetic Medicine, and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Atsushi KuboLaboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.ORCID http://orcid.org/0000-0002-6457-5386
Takashi YamadaGraduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Takayuki AkimotoFaculty of Sport Sciences, Waseda University, Saitama, Japan.ORCID http://orcid.org/0000-0002-8874-7779
So-Ichiro FukadaLaboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan. fukada@phs.osaka-u.ac.jp.ORCID http://orcid.org/0000-0003-4051-5108

Funding

Japan Agency for Medical Research and Development (AMED) JP24ama121054, JP25ama121054, JP24ama121052, and JP25ama121052MEXT | Japan Society for the Promotion of Science (JSPS) 19H04000, 20K21757, 22H03466, 25H01098,National Natural Science Foundation of China (National Science Foundation of China) 32300666
6 · The paper itself

Abstract

Quiescent muscle stem cells (MuSCs) respond to exercise; however, the coordinated regulation of increased loading, exerkines, and quiescence signaling remains unclear. We found that increased loading reduces calcitonin receptor (CalcR) expression, and forced activation of protein kinase A (PKA), a downstream of CalcR signaling, suppresses MuSC proliferation. Although MuSC-specific Calcr knockout (C-cKO) alone is insufficient, exercised C-cKO mice exhibit significant MuSC proliferation independent of increased loading. Reinforcement of CalcR signaling, either through PKA induction or Yap1 depletion, suppresses MuSC proliferation. Load-independent MuSC proliferation is also suppressed by the deletion of gp130 in C-cKO mice. Serum from exercised mice recapitulates MuSC proliferation in all analyzed muscles of sedentary C-cKO mice, which is abrogated by anti-IL-6 antibodies, and we find cross-talk between CalcR and gp130 signaling via Yap1 phosphorylation. Together, our findings reveal an integrated mechanism by which increased loading, exerkine-gp130, and CalcR signaling converge to fine-tune MuSC activity during exercise.

Indexed as

Muscle, SkeletalPhysical Conditioning, AnimalReceptors, CalcitoninStem CellsAdaptor Proteins, Signal TransducingAnimalsCell ProliferationCyclic AMP-Dependent Protein KinasesCytokine Receptor gp130Down-RegulationMaleMiceMice, Inbred C57BLMice, KnockoutPhosphorylationSignal TransductionAdaptor Proteins, Signal TransducingCyclic AMP-Dependent Protein KinasesCytokine Receptor gp130Receptors, CalcitoninYap1 protein, mouseYAP-Signaling Proteins

Identifiers

PMID41298450
PMCPMC12658206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.